BridgeBio's Acoramidis Cuts Risk Within Weeks In Rare Heart Condition

BridgeBio Pharma, Inc. (NASDAQ: BBIO) on Sunday presented data from the ATTRibute-CM study. The study showed that acoramidis reduced cumulative cardiovascular outcomes, including cardiovascular ...

New framework set to guide data reuse of public microbiome data

An international study surveying microbiome scientists found that when it comes to data reuse, a universal set of ethical guidelines driven by the scientific community needs to be adapted.
EurekAlert!

Is experiencing extreme weather events linked to climate action?

Could experiencing devastating floods, widespread wildfires, or record-breaking heatwaves be linked to the way people perceive climate action? Do people in different countries attribute these events ...

IBD and MarketWatch's sixth annual survey honors most trusted financial companies

Joining USAA on the list of the four most-trusted banks are Chime, a fintech company that partners with FDIC-insured banks; Capital One Bank, part of Capital One Financial (COF); and Chase Bank, owned ...
IEEE

DSleepNet: Disentanglement Learning for Personal Attribute-Agnostic Three-Stage Sleep Classification Using Wearable Sensing Data

Abstract: Long-term non-invasive sleep stage monitoring is instrumental in comprehending the progression of sleep disorders, cardiovascular diseases, and the interplay between sleep, type 2 diabetes, ...